Mangiferin ameliorates scopolamine-induced learning deficits in mice

Biological and Pharmaceutical Bulletin

Volumn 32, Issue 2, 2009, Pages 242-246

  Jung, Kangsik ^a   Lee, Bomi ^a   Han, Sang Jun ^a   Ryu, Jong Hoon ^a   Kim, Dong Hyun ^a  

^a Kyung Hee University   (South Korea)

Author keywords

Acetylcholinesterase; BV 2 cell; Mangiferin; Memory; Tumor necrosis factor

Indexed keywords

ACETYLCHOLINE; ANEMARRHENA ASPHODELOIDES EXTRACT; ANTIDEPRESSANT AGENT; ANTIDIABETIC AGENT; CHOLINESTERASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MANGIFERIN; SCOPOLAMINE; TACRINE; TUMOR NECROSIS FACTOR ALPHA;

ANEMARRHENA ASPHODELOIDES; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIPYRETIC ACTIVITY; ARTICLE; CHINESE MEDICINE; CHOLINERGIC NERVE CELL; CONTROLLED STUDY; DOSE RESPONSE; ESCAPE BEHAVIOR; IC 50; LEARNING DISORDER; LONG TERM MEMORY; MAZE TEST; MEMORY DISORDER; MICROGLIA; MOUSE; NONHUMAN; PASSIVE AVOIDANCE; SWIMMING;

ACETYLCHOLINE; ACETYLCHOLINESTERASE; ANIMALS; AVOIDANCE LEARNING; BLOTTING, WESTERN; CELL LINE; CHOLINESTERASE INHIBITORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HIPPOCAMPUS; LEARNING DISORDERS; MALE; MAZE LEARNING; MEMORY; MICE; MICE, INBRED ICR; MUSCARINIC ANTAGONISTS; NF-KAPPA B; SCOPOLAMINE; TUMOR NECROSIS FACTOR-ALPHA; XANTHONES;

EID: 60749131389     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.32.242     Document Type: Article

References (25)

1. Davies P., Maloney A. J., Lancet, 2, 1403 (1976).
2. Perry E. K., Tomlinson B. E., Blessed G., Bergmann K., Gibson P. H., Perry R. H., Br. Med. J., 2, 1457-1459 (1978).
3. Doody R. S., Gerontology, 45 (Suppl. 1), 23-32 (1999).
4. Dong J. X., Han G. Y. PlantaMed., 57, 460-162 (1991).
5. Iida Y., Oh K. B., Saito M., Matsuoka H., Kurata H., Natsume M., Abe H., J. Agric. Food Chem., 47, 584-587 (1999).
6. Oh J. K., Hyun S. Y., Oh H. R., Jung J. W., Park C., Lee S. Y., Park J. H., Kim S. Y., Kim K. H., Kim Y. K., Ryu J. H., Biol. Pharm. Bull., 30, 38-43 (2007).
7. Takahashi M., Konno C., Hikino H., Planta Med., 51, 100-102 (1985).
8. Ren L.-X., Luo Y.-F., Li X., Zuo D.-Y., Wu Y.-L., Biol. Pharm. Bull., 29, 2304-2306 (2006).
9. Hu Y., Xia Z., Sun Q., Orsi A., Rees D., Brain Res., 1060, 26-39 (2005).
10. Ellman G. L., Courtney K. D., Andres V Jr., Feather-Stone R. M., Biochem. Pharmacol., 7, 88-95 (1961).
11. Kim D. H., Jeon S. J., Son K. H., Jung J. W., Lee S., Yoon B. H., Lee J. J., Cho Y. W., Ceong J. H., Ko K. H., Ryu J. H., Neurobiol. Learn. Mem., 87, 536-546 (2007).
12. Lee H. S., Han S. Y., Bae E. A., Huh C. S., Ahn Y. T., Lee J. H., Kim D. H., Int. Immunopharmacol., 8, 574-580 (2008).
13. Chao C. C., Hu S., Molitor T. W., Shaskan E. G., Peterson P. K., J. Immunol., 149, 2736-2741 (1992).
14. Bae E. A., Kim E. J., Park J. S., Kim H. S., Ryu J. H., Kim D. H., Planta Med., 72, 627-633 (2006).
15. Bejar C., Wang R. H., Weinstock M., Eur. J. Pharmacol., 383, 231-240 (1999).
16. Beatty W. W., Butters N., Janowsky D. S., Eur. J. Clin. Invest., 28, 944-949 (1998).
17. Ebert U., Kirch W., Eur. J. Clin. Invest., 28, 944-949 (1998).
18. Li T. J., Qiu Y., Yang P. Y., Rui Y. C., Chen W. S., Neurosci. Lett., 421, 147-151 (2007).
19. Ouyang S., Sun L. S., Guo S. L., Liu X., Xu J. P., Di Yi Jun Yi Da Xue Xue Bao, 25, 121-126 (2005).
20. Morris R., J. Neurosci. Methods, 11, 47-60 (1984).
21. Dar A., Faizi S., Naqvi S., Roome T., Zikr-ur-Rehman S., Ali M., Fir-dous S., Moin S. T., Biol. Pharm. Bull., 28, 596-600 (2005).
22. Ibarretxe G., Sanchez-Gomez M. V, Campos-Esparza M. R., Alberdi E., Matute C., Glia, 53, 201-211 (2006).
23. Leiro J., Arranz J. A., Yanez M., Ubeira F. M., Sanmartin M. L., Orallo F., Int. Immunopharmacol., 4, 763-778 (2004).
24. Sato T., Kawamoto A., Tamura A., Tatsumi Y., Fujii T., Chem. Pharm. Bull., 40, 721-724 (1992).
25. Gottlieb M., Leal-Campanario R., Campos-Esparza M. R., Sanchez- Gomez M. V., Alberdi E., Arranz A., Delgado-Garcia J. M., Grart A., Matute C., Neurobiol. Dis., 23, 374-386 (2006).